Good Clinical Practice (GCP)
Full course · Clinical Research Foundations
Free Lesson Preview
This lesson is part of a complete GCP track — 2 courses, quizzes, a final exam, and a free verifiable credential. The optional $29 PDF certificate is recognized by 18+ trial sponsors.
Start learning for freeAlready enrolled? Sign in
Why research participants are essential partners in clinical trials, what rights protect them, and how the research community is working to make trials more accessible and representative.
What you will learn6 objectives
By the end of this lesson, you will be able to:
Clinical trials cannot exist without people willing to participate in them. This may seem obvious, but it bears repeating: every drug in your medicine cabinet, every vaccine on the immunization schedule, every medical device that saves lives in emergency rooms was tested first in human volunteers. Those volunteers accepted uncertainty and risk so that you and I could have treatments that work.
Consider what this means. Before a treatment can be approved by the FDA or any regulatory authority, it must be tested in clinical trials. Phase 1 trials focus on safety, tolerability, and pharmacokinetics in small groups of volunteers. Phase 2 trials evaluate preliminary efficacy while continuing to assess safety. Phase 3 trials, often involving thousands of participants across dozens of countries, generate the evidence that determines whether a treatment works well enough to be approved.
Each participant in these trials is doing something remarkable. They are taking a medication that has never been proven to work in humans, or agreeing to be randomly assigned to receive either a promising new treatment or a placebo, or allowing researchers to collect blood samples and monitor their health in ways that go beyond ordinary medical care. They do this knowing that they personally may not benefit, knowing that the trial may fail, knowing that something unexpected could go wrong.
Progress saves itself — finish reading and this lesson completes
This is why we say participants are at the heart of clinical research. Without their generosity, medical progress would stop.
